In the press

Matthew Read comments on the EWIT board’s difficult position in Investment Week

Biotech trusts top performance charts in February

Matthew Read comments on EWIT board challenges in Linus Uhlig’s article:

“It is clear that the board has been placed in an exceptionally difficult position: trying to act for all shareholders while a significant minority investor seeks to railroad others and impose its own agenda in what looks like an attempt to gather assets under management.”

Read the article here